These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity. Lehmann AA; Kirchenbaum GA; Zhang T; Reche PA; Lehmann PV Front Immunol; 2021; 12():635942. PubMed ID: 34127926 [TBL] [Abstract][Full Text] [Related]
9. The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated. Shahbaz S; Xu L; Sligl W; Osman M; Bozorgmehr N; Mashhouri S; Redmond D; Perez Rosero E; Walker J; Elahi S J Immunol; 2021 Aug; 207(4):1099-1111. PubMed ID: 34312258 [TBL] [Abstract][Full Text] [Related]
10. Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases. Sen K; Datta S; Ghosh A; Jha A; Ahad A; Chatterjee S; Suranjika S; Sengupta S; Bhattacharya G; Shriwas O; Avula K; Kshatri J; Prasad P; Swain R; Parida AK; Raghav SK Front Immunol; 2021; 12():733539. PubMed ID: 34899693 [TBL] [Abstract][Full Text] [Related]
11. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients. Mazzoni A; Maggi L; Capone M; Spinicci M; Salvati L; Colao MG; Vanni A; Kiros ST; Mencarini J; Zammarchi L; Mantengoli E; Menicacci L; Caldini E; Romagnani S; Liotta F; Morettini A; Rossolini GM; Bartoloni A; Cosmi L; Annunziato F Eur J Immunol; 2020 Dec; 50(12):2013-2024. PubMed ID: 33080068 [TBL] [Abstract][Full Text] [Related]
12. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals. Stanczak MA; Sanin DE; Apostolova P; Nerz G; Lampaki D; Hofmann M; Steinmann D; Krohn-Grimberghe M; Thimme R; Mittler G; Waller CF; Pearce EJ; Pearce EL Nat Commun; 2021 Apr; 12(1):2133. PubMed ID: 33837219 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively. Caicedo MS; Flores V; Padilla A; Lauryn S; Jacobs JJ; Hallab NJ J Orthop Surg Res; 2021 Jun; 16(1):415. PubMed ID: 34193239 [TBL] [Abstract][Full Text] [Related]
15. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19. Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615 [TBL] [Abstract][Full Text] [Related]
16. SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study. Casado JL; Häemmerle J; Vizcarra P; Velasco H; Velasco T; Fernandez-Escribano M; Vallejo A Clin Microbiol Infect; 2021 Jun; 27(6):916.e1-916.e4. PubMed ID: 33667629 [TBL] [Abstract][Full Text] [Related]
17. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4 Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 and the role of cytokines in this disease. Hasanvand A Inflammopharmacology; 2022 Jun; 30(3):789-798. PubMed ID: 35505267 [TBL] [Abstract][Full Text] [Related]
19. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19. Hasichaolu ; Zhang X; Li X; Li X; Li D Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223 [TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Long QX; Tang XJ; Shi QL; Li Q; Deng HJ; Yuan J; Hu JL; Xu W; Zhang Y; Lv FJ; Su K; Zhang F; Gong J; Wu B; Liu XM; Li JJ; Qiu JF; Chen J; Huang AL Nat Med; 2020 Aug; 26(8):1200-1204. PubMed ID: 32555424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]